vs
Side-by-side financial comparison of Danaher Corporation (DHR) and Freeport-McMoRan (FCX). Click either name above to swap in a different company.
Danaher Corporation is the larger business by last-quarter revenue ($6.0B vs $5.3B, roughly 1.1× Freeport-McMoRan). Danaher Corporation runs the higher net margin — 17.3% vs 10.7%, a 6.6% gap on every dollar of revenue. On growth, Danaher Corporation posted the faster year-over-year revenue change (3.7% vs -10.4%). Over the past eight quarters, Danaher Corporation's revenue compounded faster (1.8% CAGR vs -7.9%).
Danaher CorporationDHREarnings & Financial Report
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments,...
Freeport-McMoRan Inc., often called Freeport, is an American mining company based in the Freeport-McMoRan Center, in Phoenix, Arizona. The company is the world's largest producer of molybdenum, a major copper producer and operates the world's largest gold mine, the Grasberg mine in Papua, Indonesia.
DHR vs FCX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $6.0B | $5.3B |
| Net Profit | $1.0B | $565.0M |
| Gross Margin | 60.3% | 12.4% |
| Operating Margin | 22.6% | 15.4% |
| Net Margin | 17.3% | 10.7% |
| Revenue YoY | 3.7% | -10.4% |
| Net Profit YoY | 7.9% | -21.6% |
| EPS (diluted) | $1.45 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $6.0B | — | ||
| Q4 25 | $6.8B | $5.3B | ||
| Q3 25 | $6.1B | $6.8B | ||
| Q2 25 | $5.9B | $7.5B | ||
| Q1 25 | $5.7B | $5.6B | ||
| Q4 24 | $6.5B | $5.9B | ||
| Q3 24 | $5.8B | $6.7B | ||
| Q2 24 | $5.7B | $6.4B |
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.2B | $565.0M | ||
| Q3 25 | $908.0M | $1.2B | ||
| Q2 25 | $555.0M | $1.5B | ||
| Q1 25 | $954.0M | $793.0M | ||
| Q4 24 | $1.1B | $721.0M | ||
| Q3 24 | $818.0M | $1.2B | ||
| Q2 24 | $907.0M | $1.3B |
| Q1 26 | 60.3% | — | ||
| Q4 25 | 58.0% | 12.4% | ||
| Q3 25 | 58.2% | 29.2% | ||
| Q2 25 | 59.3% | 34.2% | ||
| Q1 25 | 61.2% | 24.3% | ||
| Q4 24 | 59.5% | 27.0% | ||
| Q3 24 | 58.7% | 30.0% | ||
| Q2 24 | 59.7% | 31.5% |
| Q1 26 | 22.6% | — | ||
| Q4 25 | 22.0% | 15.4% | ||
| Q3 25 | 19.1% | 28.9% | ||
| Q2 25 | 12.8% | 32.3% | ||
| Q1 25 | 22.2% | 23.4% | ||
| Q4 24 | 21.8% | 21.1% | ||
| Q3 24 | 16.5% | 29.0% | ||
| Q2 24 | 20.3% | 32.0% |
| Q1 26 | 17.3% | — | ||
| Q4 25 | 17.5% | 10.7% | ||
| Q3 25 | 15.0% | 18.3% | ||
| Q2 25 | 9.3% | 20.6% | ||
| Q1 25 | 16.6% | 14.2% | ||
| Q4 24 | 16.6% | 12.3% | ||
| Q3 24 | 14.1% | 18.5% | ||
| Q2 24 | 15.8% | 20.0% |
| Q1 26 | $1.45 | — | ||
| Q4 25 | $1.69 | — | ||
| Q3 25 | $1.27 | $0.46 | ||
| Q2 25 | $0.77 | $0.53 | ||
| Q1 25 | $1.32 | $0.24 | ||
| Q4 24 | $1.50 | — | ||
| Q3 24 | $1.12 | $0.36 | ||
| Q2 24 | $1.22 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $3.8B |
| Total DebtLower is stronger | — | $9.4B |
| Stockholders' EquityBook value | — | $18.9B |
| Total Assets | — | $58.2B |
| Debt / EquityLower = less leverage | — | 0.50× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $3.8B | ||
| Q3 25 | — | $4.3B | ||
| Q2 25 | — | $4.5B | ||
| Q1 25 | — | $4.4B | ||
| Q4 24 | — | $3.9B | ||
| Q3 24 | — | $5.0B | ||
| Q2 24 | — | $5.3B |
| Q1 26 | — | — | ||
| Q4 25 | $18.4B | $9.4B | ||
| Q3 25 | $16.9B | — | ||
| Q2 25 | $17.4B | — | ||
| Q1 25 | $16.5B | $9.4B | ||
| Q4 24 | $16.0B | $8.9B | ||
| Q3 24 | $17.5B | $9.7B | ||
| Q2 24 | $17.0B | $9.4B |
| Q1 26 | — | — | ||
| Q4 25 | $52.5B | $18.9B | ||
| Q3 25 | $51.1B | $18.7B | ||
| Q2 25 | $52.3B | $18.2B | ||
| Q1 25 | $50.8B | $17.7B | ||
| Q4 24 | $49.5B | $17.6B | ||
| Q3 24 | $51.3B | $17.5B | ||
| Q2 24 | $49.9B | $17.4B |
| Q1 26 | — | — | ||
| Q4 25 | $83.5B | $58.2B | ||
| Q3 25 | $79.9B | $56.8B | ||
| Q2 25 | $81.6B | $56.5B | ||
| Q1 25 | $79.1B | $56.0B | ||
| Q4 24 | $77.5B | $54.8B | ||
| Q3 24 | $80.6B | $55.4B | ||
| Q2 24 | $78.6B | $54.6B |
| Q1 26 | — | — | ||
| Q4 25 | 0.35× | 0.50× | ||
| Q3 25 | 0.33× | — | ||
| Q2 25 | 0.33× | — | ||
| Q1 25 | 0.32× | 0.53× | ||
| Q4 24 | 0.32× | 0.51× | ||
| Q3 24 | 0.34× | 0.55× | ||
| Q2 24 | 0.34× | 0.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.3B | $693.0M |
| Free Cash FlowOCF − Capex | — | $-312.0M |
| FCF MarginFCF / Revenue | — | -5.9% |
| Capex IntensityCapex / Revenue | 4.0% | 19.1% |
| Cash ConversionOCF / Net Profit | 1.28× | 1.23× |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.1B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $2.1B | $693.0M | ||
| Q3 25 | $1.7B | $1.7B | ||
| Q2 25 | $1.3B | $2.2B | ||
| Q1 25 | $1.3B | $1.1B | ||
| Q4 24 | $2.0B | $1.4B | ||
| Q3 24 | $1.5B | $1.9B | ||
| Q2 24 | $1.4B | $2.0B |
| Q1 26 | — | — | ||
| Q4 25 | $1.7B | $-312.0M | ||
| Q3 25 | $1.4B | $608.0M | ||
| Q2 25 | $1.1B | $934.0M | ||
| Q1 25 | $1.1B | $-114.0M | ||
| Q4 24 | $1.5B | $197.0M | ||
| Q3 24 | $1.2B | $673.0M | ||
| Q2 24 | $1.1B | $840.0M |
| Q1 26 | — | — | ||
| Q4 25 | 25.5% | -5.9% | ||
| Q3 25 | 22.6% | 8.9% | ||
| Q2 25 | 18.4% | 12.4% | ||
| Q1 25 | 18.4% | -2.0% | ||
| Q4 24 | 23.0% | 3.4% | ||
| Q3 24 | 21.0% | 10.1% | ||
| Q2 24 | 19.7% | 13.1% |
| Q1 26 | 4.0% | — | ||
| Q4 25 | 5.4% | 19.1% | ||
| Q3 25 | 4.8% | 15.5% | ||
| Q2 25 | 4.2% | 16.8% | ||
| Q1 25 | 4.3% | 21.0% | ||
| Q4 24 | 7.9% | 21.1% | ||
| Q3 24 | 5.1% | 17.9% | ||
| Q2 24 | 5.0% | 17.4% |
| Q1 26 | 1.28× | — | ||
| Q4 25 | 1.77× | 1.23× | ||
| Q3 25 | 1.83× | 1.33× | ||
| Q2 25 | 2.41× | 1.42× | ||
| Q1 25 | 1.36× | 1.33× | ||
| Q4 24 | 1.86× | 1.99× | ||
| Q3 24 | 1.85× | 1.51× | ||
| Q2 24 | 1.56× | 1.53× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DHR
Segment breakdown not available.
FCX
| Morenci | $2.5B | 47% |
| Grasberg Segment | $964.0M | 18% |
| Copper In Concentrates | $934.0M | 18% |
| Molybdenum | $541.0M | 10% |
| Gold | $388.0M | 7% |
